S&P 500: 680.33 -0.9% NASDAQ 100: 601.58 -1.1% Dow Jones: 485.52 -0.8%

Artivion, Inc.

AORT Healthcare
$38.62 +$0.07 (0.18%)
Market Cap: $1.85 B
Gurus Holding
4
Popularity Rank
#2617
% of Shares Held
1.62%
Net Activity (Q4 2025)
-$8.56 M

Guru Ownership Trend

Guru Analysis for Artivion, Inc. (AORT)

Artivion, Inc. (AORT), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q4 2025, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $29.99 M.

Top institutional holders include Chuck Royce and First Eagle Investment.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $8.56 M net outflow during the quarter.

Recent activity highlights Joel Greenblatt who increased their stake by 30.8%. Conversely, Chuck Royce reduced exposure by 18.3%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q4 2025)

+$266,271.22
Total Buy Value
New Buys 0
Additions 2
-$8.83 M
Total Sell Value
Reductions 2
Sold Out 1

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
3
Net Buyers
2

FAQs for Artivion, Inc. (AORT)

Major holders include Chuck Royce ($19.74 M), First Eagle Investment ($14 M), Joel Greenblatt ($877,993). According to the latest reported data, 4 tracked investment managers collectively hold approximately 776,466 shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $8.56 M, with 2 managers increasing positions and 3 managers reducing holdings.

During the most recent reporting period, 2 managers trimmed their positions, while 1 fully exited AORT. The total reported sell value was $8.83 M.

Yes, 0 managers opened new positions in AORT, and 2 increased their existing holdings. The total reported buy value was $266,271.22.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.20% Reduce -18.3% 432,782 $19.74 M Q4 2025
0.02% Reduce -9.8% 306,893 $14 M Q4 2025
0.00% Add 30.8% 19,250 $877,993 Q4 2025
0.00% Add 8.1% 17,541 $800,044 Q4 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form